Medicine guide

Efavirenz Aurobindo 600 mg

As listed in the register: Efavirenz Aurobindo 600 mg, filmomhulde tabletten

600 mg · filmomhulde tablet

  • Prescription only
  • Antibiotics, antivirals and antifungals taken into the body
Active substance
Efavirenz
Made by
Aurobindo Pharma B.V.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupAntibiotics, antivirals and antifungals taken into the bodyJ05AG03

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (Efavirenz). It describes the substance, not this exact product.

Efavirenz is an antiviral drug [see Microbiology ( 12.4 )].

Peak level after3–5 h
Half-life40–55 h
Mostly cleared after≈ 10 daysfive half-lives — our arithmetic
PeakHalf gone10 days0
The shape is a standard model drawn from the two times above, not a measurement. How fast a medicine acts and wears off also depends on the dose, the form and the person.
How the body breaks it down

Studies in humans and in vitro studies using human liver microsomes have demonstrated that efavirenz is principally metabolized by the cytochrome P450 system to hydroxylated metabolites with subsequent glucuronidation of these hydroxylated metabolites.

How it leaves the body

Renal impairment: The pharmacokinetics of efavirenz have not been studied in patients with renal insufficiency; however, less than 1% of efavirenz is excreted unchanged in the urine, so the impact of renal impairment on efavirenz elimination should be minimal.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2024-06-28

Safety of the active substance

From the US prescribing label for the same active substance (Efavirenz). It describes the substance, not this exact product.

Must not be used by
  • Efavirenz is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product..
  • Coadministration of efavirenz with elbasvir and grazoprevir is contraindicated [ see Warnings and Precautions ( 5.1 ) and Drug Interactions ( 7.1 ) ]..
  • Patients with previously demonstrated hypersensitivity (e.g., Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions to any of the components of this product.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byAurobindo Pharma B.V.
Active substanceEfavirenz
Used inAntibiotics, antivirals and antifungals taken into the body
Strength600 mg
Formfilmomhulde tablet
ClassificationJ05AG03 · Antibiotics, antivirals and antifungals taken into the body
Routeoraal gebruik
Dispensing (as stated by the register)Uitsluitend recept
Name in the registerEfavirenz Aurobindo 600 mg, filmomhulde tabletten
RVG113833

Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician

Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.